1. Home
  2. YPF vs BBIO Comparison

YPF vs BBIO Comparison

Compare YPF & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YPF
  • BBIO
  • Stock Information
  • Founded
  • YPF 1977
  • BBIO 2015
  • Country
  • YPF Argentina
  • BBIO United States
  • Employees
  • YPF N/A
  • BBIO N/A
  • Industry
  • YPF Integrated oil Companies
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • YPF Energy
  • BBIO Health Care
  • Exchange
  • YPF Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • YPF 10.8B
  • BBIO 12.5B
  • IPO Year
  • YPF 1993
  • BBIO 2019
  • Fundamental
  • Price
  • YPF $35.66
  • BBIO $70.06
  • Analyst Decision
  • YPF Buy
  • BBIO Strong Buy
  • Analyst Count
  • YPF 5
  • BBIO 19
  • Target Price
  • YPF $43.60
  • BBIO $74.79
  • AVG Volume (30 Days)
  • YPF 2.5M
  • BBIO 2.7M
  • Earning Date
  • YPF 11-07-2025
  • BBIO 10-29-2025
  • Dividend Yield
  • YPF N/A
  • BBIO N/A
  • EPS Growth
  • YPF N/A
  • BBIO N/A
  • EPS
  • YPF N/A
  • BBIO N/A
  • Revenue
  • YPF $15,662,491,497.00
  • BBIO $353,780,000.00
  • Revenue This Year
  • YPF $49.98
  • BBIO $123.32
  • Revenue Next Year
  • YPF N/A
  • BBIO $73.46
  • P/E Ratio
  • YPF N/A
  • BBIO N/A
  • Revenue Growth
  • YPF 41.18
  • BBIO 62.46
  • 52 Week Low
  • YPF $22.82
  • BBIO $25.34
  • 52 Week High
  • YPF $47.43
  • BBIO $71.65
  • Technical
  • Relative Strength Index (RSI)
  • YPF 54.33
  • BBIO 68.10
  • Support Level
  • YPF $34.42
  • BBIO $64.41
  • Resistance Level
  • YPF $39.38
  • BBIO $67.71
  • Average True Range (ATR)
  • YPF 1.63
  • BBIO 2.81
  • MACD
  • YPF -0.58
  • BBIO 0.23
  • Stochastic Oscillator
  • YPF 22.56
  • BBIO 86.49

About YPF YPF Sociedad Anonima

YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. Its upstream segment consists of exploration, development, and production of crude oil, natural gas, and LPG. Its downstream segment include refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG and bio-fuels. Gas and Power segment performs activities related to natural gas transportation to third parties and Downstream segment. Central Administration and Others includes activities performed by the Group not falling under the business segments. It generates maximum revenue from downstream segment.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: